Citadel Advisors - AOXING PHARMACEUTICAL CO INC ownership

Quarter-by-quarter ownership
Citadel Advisors ownership history of AOXING PHARMACEUTICAL CO INC
ValueSharesWeighting
Q3 2017$10,000
-50.0%
61,329
-3.9%
0.00%
Q4 2016$20,000
+233.3%
63,789
+527.4%
0.00%
Q3 2016$6,000
-53.8%
10,168
-50.0%
0.00%
Q2 2016$13,000
-23.5%
20,324
-19.6%
0.00%
Q1 2016$17,000
+41.7%
25,270
+46.0%
0.00%
Q4 2015$12,000
+71.4%
17,304
-18.9%
0.00%
Q4 2014$7,000
-12.5%
21,347
-43.2%
0.00%
Q3 2014$8,0000.0%37,614
+42.1%
0.00%
Q2 2014$8,000
-42.9%
26,478
-21.7%
0.00%
Q1 2014$14,000
+7.7%
33,832
-36.1%
0.00%
Q4 2013$13,000
-7.1%
52,911
-1.0%
0.00%
Q3 2013$14,00053,4490.00%
Other shareholders
AOXING PHARMACEUTICAL CO INC shareholders Q4 2017
NameSharesValueWeighting ↓
Rotella Capital Management, Inc. 30,499$53,0000.04%
Evercore Wealth Management, LLC 13,158$23,0000.00%
BlackRock Fund Advisors 105,895$185,0000.00%
BlackRock Investment Management, LLC 6,274$11,0000.00%
Tower Research Capital LLC (TRC) 8$00.00%
AQR Capital Management 45,700$80,0000.00%
View complete list of AOXING PHARMACEUTICAL CO INC shareholders